CPhI logo
  • Products
  • Suppliers
  • Sourcing Requests
  • 中文站
  • Sign in Join free
Post Sourcing Request Post Sourcing Request Sourcing Request List Exhibition
  • Home
  • Products
  • Suppliers
  • Content Hub
  • Industry Insights
  • Events
  • Service & Membership
  • For Suppliers

    My Account

    My Online Store

    My EZSourcing

    View Sourcing Requests

    Customer Service

  • For Buyer

    Search Products & Suppliers

    Products Directory Suppliers Discovery Post EZSourcing

    Service

    Buyer Sourcing Event Contact Us

    Quick links

    My Favorites Recent Visit History
  • Industry Data
  • Features
  • Market News
  • Products Guide
  • Brand Story
You are here:   Industry Insights > Market News

Market News

  • FDA approves drug for adults with rare form of bone marrow disorder Market news FDAMarch 02, 2022
    FDA has granted accelerated approval for Vonjo (pacritinib) capsules to treat adults who have a rare form of a bone marrow disorder known as intermediate or high-risk primary or secondary myelofibrosis...
  • BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development Market news b3cnewswireMarch 01, 2022
    German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Pharmacological...
  • Approved first generic for Apokyn injection cartridges requires separately packaged pen Market news FDAFebruary 28, 2022
    The U.S. Food and Drug Administration has approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility “off” episodes...
  • FDA Approves Treatment for Wider Range of Patients with Heart Failure Market news FDAFebruary 25, 2022
    ​The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.
  • CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021 Market news PharmaSources.comFebruary 24, 2022
    Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
  • Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7% Market news PharmaSources.comFebruary 24, 2022
    Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
  • V-01 as a Sequential Booster Can Produce Good Protection against Omicron ---- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma Market news PharmaSources.comFebruary 21, 2022
    Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19.
  • Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange Market news PharmaSources.comFebruary 18, 2022
    The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157), today announced the proposed listing...
  • SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE Market news PharmaSources.comFebruary 18, 2022
    SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research...
  • IgY antibody technology against SARS-CoV-2 unveiled Market news PharmaSources.comFebruary 18, 2022
    An IgY neutralizing antibody, which is claimed to inhibit the activity of SARS-CoV-2, the novel coronavirus that causes COVID-19, by over 99 percent, was launched in Shenzhen on Monday, according to Shenzhen Special Zone Daily.
Previous page 1 2 3 4 5 6 7 8 ... 4092 4093 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPhI China
P-MEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
  • Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
  • Links:
    CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
  • Follow Us:

  • CPhI logo Pharma Sources Insight JUNE2022
  • PharmaSources@imsinoexpo.com
  • +86-13621645194
  • We Want Your Feedback